The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding .
Notice of Funding Opportunities
Title
Announcement Number
Activity Code
Clinical Trials Status
Expiration Date
Program Official
Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer
NOT-CA-22-085
05/08/2027
Sharon Ross, Ph.D., M.P.H.
Notice of Special Interest (NOSI): Career Development Opportunities for Research Within the Mission of the Division of Cancer Prevention at the National Cancer Institute
NOT-CA-23-035
11/13/2024
Jessica Faupel-Badger, Ph.D., M.P.H.
Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer
NOT-CA-23-018
09/08/2024
Mechanisms that Impact Cancer Risk after Bariatric Surgery
PAR-21-332 (R21 Clinical Trial Not Allowed)
R21
Clinical Trial Not Allowed
09/08/2024
Edward Sauter, M.D., Ph.D.
Cancer Prevention and Control Clinical Trials Planning Grant Program
PAR-22-173 (R34 Clinical Trials Optional)
R34
05/08/2025
Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cancer Prevention and Control Clinical Trials Planning Grant Program
PAR-22-174 (U34 Clinical Trials Optional)
U34
05/08/2025
Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research
PAR-22-099 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
05/08/2025
Richard Mazurchuk, Ph.D.
NCI Clinical and Translational Exploratory/Developmental Studies
PAR-22-216 (R21 Clinical Trial Optional)
R21
Clinical Trial Optional
07/02/2025
Marjorie Perloff, M.D.
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment
RFA-NS-22-034 (R01 Clinical Trial Not Allowed)
R01
Clinical Trial Not Allowed
12/07/2024
Rachel Altshuler, Ph.D.
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes
PAR-22-131 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
09/08/2025
Richard Mazurchuk, Ph.D.